The Field of Blood Cancers: How Have We Evolved

In this episode of Doc to Doc, we explore groundbreaking advances in the treatment of blood cancers with two of the field’s leading experts:
Dr. Guenther Koehne, Deputy Director and Chief of Blood and Marrow Transplant, Hematologic Oncology and Benign Hematology, and Dr. Firas El Chaer, Chief of Leukemia Services and Medical Director of Infusion — both from Baptist Health Miami Cancer Institute.

From precision-targeted therapies and measurable residual disease (MRD) to cutting-edge immunotherapies like (CAR) T-cell therapy, BiTEs, and NK-cell approaches — we cover the evolving tools that are reshaping treatment protocols across leukemia, myeloma, MDS, and lymphoma.

Topics Covered:
✅ MRD-guided treatment decisions
✅ Overcoming drug resistance with combination strategies
✅ Targeted therapies for actionable mutations
✅ The expanding role of CAR T, BiTEs, and NK cells
✅ Clinical application and access at Baptist Health

If you're an oncologist, hematologist, or transplant specialist navigating the complexity of hematologic malignancies — this conversation will help sharpen your clinical edge.

🔔 Subscribe for more expert insights: @BaptistHealthSF
📍 Learn more at MiamiCancerInstitute.com